

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | fibril organization (GO:0097435) | 8.87202233 |
| 2 | glutathione derivative metabolic process (GO:1901685) | 8.40832084 |
| 3 | glutathione derivative biosynthetic process (GO:1901687) | 8.40832084 |
| 4 | O-glycan processing (GO:0016266) | 8.19408724 |
| 5 | digestive system process (GO:0022600) | 7.87778970 |
| 6 | response to iron ion (GO:0010039) | 7.64164307 |
| 7 | protein autoprocessing (GO:0016540) | 7.62132314 |
| 8 | sulfation (GO:0051923) | 7.53596772 |
| 9 | cellular response to nitric oxide (GO:0071732) | 7.36640013 |
| 10 | regulation of proton transport (GO:0010155) | 7.31499515 |
| 11 | cellular response to zinc ion (GO:0071294) | 6.72846077 |
| 12 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 6.70887946 |
| 13 | cellular response to reactive nitrogen species (GO:1902170) | 6.32174221 |
| 14 | negative regulation of complement activation (GO:0045916) | 6.18616820 |
| 15 | glandular epithelial cell differentiation (GO:0002067) | 6.14237609 |
| 16 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 6.13623926 |
| 17 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 6.13522506 |
| 18 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 6.13522506 |
| 19 | kidney morphogenesis (GO:0060993) | 6.10434103 |
| 20 | negative regulation of digestive system process (GO:0060457) | 5.99949674 |
| 21 | protein O-linked glycosylation (GO:0006493) | 5.81491740 |
| 22 | regulation of vasculogenesis (GO:2001212) | 5.51930277 |
| 23 | production of molecular mediator of immune response (GO:0002440) | 5.50504455 |
| 24 | negative regulation of protein activation cascade (GO:2000258) | 5.45688033 |
| 25 | positive regulation of vasculogenesis (GO:2001214) | 5.33647737 |
| 26 | response to nitric oxide (GO:0071731) | 5.20986959 |
| 27 | cellular response to cadmium ion (GO:0071276) | 5.14242310 |
| 28 | regulation of integrin-mediated signaling pathway (GO:2001044) | 5.13388053 |
| 29 | negative regulation of humoral immune response (GO:0002921) | 4.99993075 |
| 30 | regulation of phospholipase A2 activity (GO:0032429) | 4.93503334 |
| 31 | fucose catabolic process (GO:0019317) | 4.79518552 |
| 32 | L-fucose metabolic process (GO:0042354) | 4.79518552 |
| 33 | L-fucose catabolic process (GO:0042355) | 4.79518552 |
| 34 | intestinal absorption (GO:0050892) | 4.73047967 |
| 35 | thyroid hormone metabolic process (GO:0042403) | 4.65794445 |
| 36 | positive regulation of endothelial cell differentiation (GO:0045603) | 4.64533846 |
| 37 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 4.53936613 |
| 38 | respiratory gaseous exchange (GO:0007585) | 4.49909353 |
| 39 | peptidyl-proline hydroxylation (GO:0019511) | 4.49172573 |
| 40 | regulation of sequestering of triglyceride (GO:0010889) | 4.45961080 |
| 41 | sulfur amino acid catabolic process (GO:0000098) | 4.43638328 |
| 42 | glutathione metabolic process (GO:0006749) | 4.37233896 |
| 43 | thyroid hormone generation (GO:0006590) | 4.34184832 |
| 44 | phospholipid scrambling (GO:0017121) | 4.26682537 |
| 45 | macrophage chemotaxis (GO:0048246) | 4.07907100 |
| 46 | regulation of endothelial cell differentiation (GO:0045601) | 3.97374274 |
| 47 | protein retention in ER lumen (GO:0006621) | 3.95984142 |
| 48 | regulation of pH (GO:0006885) | 3.94607289 |
| 49 | negative regulation of transcription by competitive promoter binding (GO:0010944) | 3.91122402 |
| 50 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.90623845 |
| 51 | phosphatidylserine metabolic process (GO:0006658) | 3.88662087 |
| 52 | polyketide metabolic process (GO:0030638) | 3.87466360 |
| 53 | doxorubicin metabolic process (GO:0044598) | 3.87466360 |
| 54 | daunorubicin metabolic process (GO:0044597) | 3.87466360 |
| 55 | embryonic foregut morphogenesis (GO:0048617) | 3.85949593 |
| 56 | xenobiotic metabolic process (GO:0006805) | 3.83584801 |
| 57 | renal absorption (GO:0070293) | 3.83466090 |
| 58 | nitric oxide biosynthetic process (GO:0006809) | 3.78656785 |
| 59 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 3.75703395 |
| 60 | atrioventricular valve morphogenesis (GO:0003181) | 3.75626457 |
| 61 | endocrine hormone secretion (GO:0060986) | 3.73520191 |
| 62 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.73407427 |
| 63 | lung secretory cell differentiation (GO:0061140) | 3.71265552 |
| 64 | protein hydroxylation (GO:0018126) | 3.66461881 |
| 65 | leukotriene metabolic process (GO:0006691) | 3.65183774 |
| 66 | low-density lipoprotein particle clearance (GO:0034383) | 3.62350898 |
| 67 | cellular response to gonadotropin stimulus (GO:0071371) | 3.61761517 |
| 68 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.61145234 |
| 69 | response to hyperoxia (GO:0055093) | 3.57867776 |
| 70 | response to increased oxygen levels (GO:0036296) | 3.57867776 |
| 71 | pH reduction (GO:0045851) | 3.52686507 |
| 72 | regulation of cardioblast differentiation (GO:0051890) | 3.50635328 |
| 73 | diacylglycerol metabolic process (GO:0046339) | 3.47170405 |
| 74 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.46992870 |
| 75 | receptor recycling (GO:0001881) | 3.43948006 |
| 76 | cellular response to arsenic-containing substance (GO:0071243) | 3.42658037 |
| 77 | induction of positive chemotaxis (GO:0050930) | 3.42126944 |
| 78 | leukotriene biosynthetic process (GO:0019370) | 3.40295913 |
| 79 | positive regulation of p38MAPK cascade (GO:1900745) | 3.39906155 |
| 80 | phosphatidylglycerol acyl-chain remodeling (GO:0036148) | 3.39860709 |
| 81 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.38691528 |
| 82 | positive regulation of lipid storage (GO:0010884) | 3.36611894 |
| 83 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.29888205 |
| 84 | one-carbon compound transport (GO:0019755) | 3.27624347 |
| 85 | retinal metabolic process (GO:0042574) | 3.25717940 |
| 86 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 3.24842584 |
| 87 | arachidonic acid secretion (GO:0050482) | 3.24680036 |
| 88 | intestinal epithelial cell development (GO:0060576) | 3.22327545 |
| 89 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.22204812 |
| 90 | cyclooxygenase pathway (GO:0019371) | 3.20175596 |
| 91 | triglyceride catabolic process (GO:0019433) | 3.18654135 |
| 92 | complement activation (GO:0006956) | 3.16483463 |
| 93 | alditol phosphate metabolic process (GO:0052646) | 3.16064169 |
| 94 | cellular response to oxygen radical (GO:0071450) | 3.15926616 |
| 95 | removal of superoxide radicals (GO:0019430) | 3.15926616 |
| 96 | cellular response to superoxide (GO:0071451) | 3.15926616 |
| 97 | progesterone metabolic process (GO:0042448) | 3.15746605 |
| 98 | ethanol oxidation (GO:0006069) | 3.15237823 |
| 99 | phosphatidylethanolamine acyl-chain remodeling (GO:0036152) | 3.14961052 |
| 100 | regulation of heart rate by cardiac conduction (GO:0086091) | 3.11492077 |
| 101 | L-serine transport (GO:0015825) | 3.09574354 |
| 102 | peptide cross-linking (GO:0018149) | 3.09040933 |
| 103 | acrosome reaction (GO:0007340) | 3.07774981 |
| 104 | regulation of complement activation (GO:0030449) | 3.06727245 |
| 105 | endothelium development (GO:0003158) | 3.06572962 |
| 106 | polyol transport (GO:0015791) | 3.02590961 |
| 107 | peptide catabolic process (GO:0043171) | 3.00231452 |
| 108 | neutrophil mediated immunity (GO:0002446) | 2.98257810 |
| 109 | response to vitamin A (GO:0033189) | 2.98147644 |
| 110 | columnar/cuboidal epithelial cell differentiation (GO:0002065) | 2.97319242 |
| 111 | complement activation, classical pathway (GO:0006958) | 2.96280302 |
| 112 | acid secretion (GO:0046717) | 2.95754573 |
| 113 | membrane raft organization (GO:0031579) | 2.95414802 |
| 114 | myelin maintenance (GO:0043217) | 2.95005861 |
| 115 | negative regulation of interleukin-2 production (GO:0032703) | 2.93428492 |
| 116 | lung vasculature development (GO:0060426) | 2.93358096 |
| 117 | 4-hydroxyproline metabolic process (GO:0019471) | 2.91566539 |
| 118 | sodium ion export (GO:0071436) | 2.91467419 |
| 119 | glomerular filtration (GO:0003094) | 2.91080053 |
| 120 | ribonucleoside bisphosphate metabolic process (GO:0033875) | 2.86900608 |
| 121 | nucleoside bisphosphate metabolic process (GO:0033865) | 2.86900608 |
| 122 | purine nucleoside bisphosphate metabolic process (GO:0034032) | 2.86900608 |
| 123 | response to interleukin-6 (GO:0070741) | 2.86657938 |
| 124 | renal filtration (GO:0097205) | 2.86235403 |
| 125 | fatty acid derivative transport (GO:1901571) | 2.85149587 |
| 126 | icosanoid transport (GO:0071715) | 2.85149587 |
| 127 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.84675592 |
| 128 | cell communication involved in cardiac conduction (GO:0086065) | 2.81774011 |
| 129 | desmosome organization (GO:0002934) | 2.80658017 |
| 130 | regulation of skeletal muscle contraction (GO:0014819) | 2.79604031 |
| 131 | regulation of macrophage activation (GO:0043030) | 2.79172047 |
| 132 | regulation of protein activation cascade (GO:2000257) | 2.78660003 |
| 133 | response to superoxide (GO:0000303) | 2.78458838 |
| 134 | regulation of metalloenzyme activity (GO:0048552) | 2.77930772 |
| 135 | hepatocyte apoptotic process (GO:0097284) | 2.77855691 |
| 136 | cGMP biosynthetic process (GO:0006182) | 2.77531193 |
| 137 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.77046233 |
| 138 | fucose metabolic process (GO:0006004) | 2.76225846 |
| 139 | regulation of p38MAPK cascade (GO:1900744) | 2.75424413 |
| 140 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.74143651 |
| 141 | growth hormone secretion (GO:0030252) | 2.73639267 |
| 142 | lipid storage (GO:0019915) | 2.72157108 |
| 143 | cardiac conduction (GO:0061337) | 2.72066561 |
| 144 | cobalamin metabolic process (GO:0009235) | 2.71653910 |
| 145 | ethanol metabolic process (GO:0006067) | 2.71587157 |
| 146 | neutral lipid catabolic process (GO:0046461) | 2.70428051 |
| 147 | acylglycerol catabolic process (GO:0046464) | 2.70428051 |
| 148 | hexose catabolic process (GO:0019320) | 2.70284221 |
| 149 | intestinal cholesterol absorption (GO:0030299) | 2.69707853 |
| 150 | epithelial cell-cell adhesion (GO:0090136) | 2.67807593 |
| 151 | response to gonadotropin (GO:0034698) | 2.67468201 |
| 152 | endocardial cushion development (GO:0003197) | 2.67056036 |
| 153 | galactose catabolic process (GO:0019388) | 2.66352024 |
| 154 | lymphangiogenesis (GO:0001946) | 2.66013152 |
| 155 | flavonoid metabolic process (GO:0009812) | 2.65915245 |
| 156 | vitamin transport (GO:0051180) | 2.65494259 |
| 157 | serine transport (GO:0032329) | 2.64896262 |
| 158 | icosanoid secretion (GO:0032309) | 2.63316374 |
| 159 | protein activation cascade (GO:0072376) | 2.63012143 |
| 160 | regulation of glomerular filtration (GO:0003093) | 2.61537985 |
| 161 | iron ion import (GO:0097286) | 2.57966483 |
| 162 | cellular response to antibiotic (GO:0071236) | 2.56323760 |
| 163 | norepinephrine metabolic process (GO:0042415) | 2.53637020 |
| 164 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.52310334 |
| 165 | heart trabecula formation (GO:0060347) | 2.52132007 |
| 166 | regulation of cholesterol storage (GO:0010885) | 2.50875325 |
| 167 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.49138153 |
| 168 | response to thyroid hormone (GO:0097066) | 2.48531721 |
| 169 | regulation of digestive system process (GO:0044058) | 2.48065527 |
| 170 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.47914187 |
| 171 | positive regulation of receptor recycling (GO:0001921) | 2.45921744 |
| 172 | transcytosis (GO:0045056) | 2.45309883 |
| 173 | regulation of lipid storage (GO:0010883) | 2.45114290 |
| 174 | toxin metabolic process (GO:0009404) | 2.44952810 |
| 175 | extracellular matrix assembly (GO:0085029) | 2.40085019 |
| 176 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.37351967 |
| 177 | regulation of cell migration involved in sprouting angiogenesis (GO:0090049) | 2.37238027 |
| 178 | prostaglandin metabolic process (GO:0006693) | 2.35821184 |
| 179 | prostanoid metabolic process (GO:0006692) | 2.35821184 |
| 180 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 2.35060238 |
| 181 | cellular hyperosmotic response (GO:0071474) | 2.34496794 |
| 182 | regulation of hippo signaling (GO:0035330) | 2.33108893 |
| 183 | hyperosmotic salinity response (GO:0042538) | 2.32832191 |
| 184 | fibroblast migration (GO:0010761) | 2.31286943 |
| 185 | adhesion of symbiont to host cell (GO:0044650) | 2.31091869 |
| 186 | maintenance of gastrointestinal epithelium (GO:0030277) | 17.9464786 |
| 187 | surfactant homeostasis (GO:0043129) | 15.8267097 |
| 188 | epithelial structure maintenance (GO:0010669) | 13.5877723 |
| 189 | chemical homeostasis within a tissue (GO:0048875) | 12.5205775 |
| 190 | digestion (GO:0007586) | 10.8508402 |
| 191 | extracellular fibril organization (GO:0043206) | 10.3015341 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 7.20076115 |
| 2 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 6.03039365 |
| 3 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 4.19462807 |
| 4 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 3.89597719 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.86259868 |
| 6 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 3.65400059 |
| 7 | GATA4_25053715_ChIP-Seq_YYC3_Human | 3.08499089 |
| 8 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.98175378 |
| 9 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.83458561 |
| 10 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.79202715 |
| 11 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.60694255 |
| 12 | SOX2_20726797_ChIP-Seq_SW620_Human | 2.54351069 |
| 13 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 2.53809991 |
| 14 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 2.39949140 |
| 15 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.39595183 |
| 16 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 2.36155698 |
| 17 | GATA6_25053715_ChIP-Seq_YYC3_Human | 2.32885865 |
| 18 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 2.31702222 |
| 19 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.31296189 |
| 20 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.23157619 |
| 21 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.12392230 |
| 22 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 2.07801602 |
| 23 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.95506383 |
| 24 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.95090771 |
| 25 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.90540174 |
| 26 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.90274389 |
| 27 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.87414944 |
| 28 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.86166913 |
| 29 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.83554513 |
| 30 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.83532939 |
| 31 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.83269505 |
| 32 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.82434850 |
| 33 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.80183779 |
| 34 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.79518987 |
| 35 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.77553216 |
| 36 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.74070063 |
| 37 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.73930527 |
| 38 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.71596184 |
| 39 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.69455233 |
| 40 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.65634243 |
| 41 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.65339246 |
| 42 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.64015916 |
| 43 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.59548425 |
| 44 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.59466523 |
| 45 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.59200208 |
| 46 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.58090830 |
| 47 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.51128853 |
| 48 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.50667784 |
| 49 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.49944010 |
| 50 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.49944010 |
| 51 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.49699499 |
| 52 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.47878380 |
| 53 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.47252286 |
| 54 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.45085449 |
| 55 | VDR_22108803_ChIP-Seq_LS180_Human | 1.44011615 |
| 56 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.41786567 |
| 57 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.41707407 |
| 58 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.41291492 |
| 59 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.38737981 |
| 60 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.35527517 |
| 61 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.34584328 |
| 62 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.34307192 |
| 63 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.33821758 |
| 64 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.30243485 |
| 65 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.29139933 |
| 66 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.25969336 |
| 67 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.25851972 |
| 68 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.25697197 |
| 69 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.23719625 |
| 70 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.21726289 |
| 71 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.20938195 |
| 72 | ATF3_27146783_Chip-Seq_COLON_Human | 1.18271209 |
| 73 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.16554206 |
| 74 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.16124767 |
| 75 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.14827516 |
| 76 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.14703447 |
| 77 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.14628943 |
| 78 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.14023193 |
| 79 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.13996082 |
| 80 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.13150174 |
| 81 | KDM2B_26808549_Chip-Seq_K562_Human | 1.12499891 |
| 82 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.09792553 |
| 83 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.09255288 |
| 84 | RXR_22108803_ChIP-Seq_LS180_Human | 1.08089846 |
| 85 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.06956529 |
| 86 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.06470216 |
| 87 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.06317507 |
| 88 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.03979467 |
| 89 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.01134718 |
| 90 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.99601837 |
| 91 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.99562968 |
| 92 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.99251472 |
| 93 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.97768431 |
| 94 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.97543260 |
| 95 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.96394745 |
| 96 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.93552364 |
| 97 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.92228410 |
| 98 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.91653722 |
| 99 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.91420741 |
| 100 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.91006395 |
| 101 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.89530553 |
| 102 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.89248164 |
| 103 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.89174439 |
| 104 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.88314854 |
| 105 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.88121848 |
| 106 | * EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.87287300 |
| 107 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.87246703 |
| 108 | CJUN_26792858_Chip-Seq_BT549_Human | 0.87113276 |
| 109 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.86659245 |
| 110 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.86659245 |
| 111 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.86197022 |
| 112 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.85088008 |
| 113 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.85088008 |
| 114 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.84921395 |
| 115 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.83770963 |
| 116 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.83511715 |
| 117 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.82944505 |
| 118 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.82768615 |
| 119 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.81820641 |
| 120 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.81542749 |
| 121 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.81429032 |
| 122 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.80877225 |
| 123 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.80774856 |
| 124 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.80444747 |
| 125 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.79722177 |
| 126 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.79579483 |
| 127 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.79395666 |
| 128 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.78484342 |
| 129 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.78059686 |
| 130 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.77805166 |
| 131 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.77805166 |
| 132 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.77805166 |
| 133 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.77488920 |
| 134 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.77395038 |
| 135 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.77174484 |
| 136 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.75929220 |
| 137 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.75553210 |
| 138 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.75135857 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004782_abnormal_surfactant_physiolog | 7.65580797 |
| 2 | MP0001873_stomach_inflammation | 5.96020996 |
| 3 | MP0001958_emphysema | 5.59772907 |
| 4 | MP0001664_abnormal_digestion | 5.13776601 |
| 5 | MP0000470_abnormal_stomach_morphology | 3.88651008 |
| 6 | MP0008995_early_reproductive_senescence | 3.68441334 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 3.55034553 |
| 8 | MP0010368_abnormal_lymphatic_system | 3.34096352 |
| 9 | MP0005670_abnormal_white_adipose | 2.85724823 |
| 10 | MP0001879_abnormal_lymphatic_vessel | 2.78612716 |
| 11 | MP0005666_abnormal_adipose_tissue | 2.61465347 |
| 12 | MP0005388_respiratory_system_phenotype | 2.43397530 |
| 13 | MP0002133_abnormal_respiratory_system | 2.43397530 |
| 14 | MP0001542_abnormal_bone_strength | 2.38363833 |
| 15 | MP0003950_abnormal_plasma_membrane | 2.28036642 |
| 16 | MP0002295_abnormal_pulmonary_circulatio | 2.11587698 |
| 17 | MP0001663_abnormal_digestive_system | 2.09179548 |
| 18 | MP0005164_abnormal_response_to | 2.00932306 |
| 19 | MP0008004_abnormal_stomach_pH | 17.4109910 |
| 20 | MP0002971_abnormal_brown_adipose | 1.92062262 |
| 21 | MP0003091_abnormal_cell_migration | 1.85957646 |
| 22 | MP0005381_digestive/alimentary_phenotyp | 1.85391630 |
| 23 | MP0004883_abnormal_blood_vessel | 1.85255005 |
| 24 | MP0006138_congestive_heart_failure | 1.81822108 |
| 25 | MP0005375_adipose_tissue_phenotype | 1.77120940 |
| 26 | MP0001666_abnormal_nutrient_absorption | 1.73637663 |
| 27 | MP0005165_increased_susceptibility_to | 1.72387624 |
| 28 | MP0010234_abnormal_vibrissa_follicle | 1.71781427 |
| 29 | MP0001177_atelectasis | 1.54632216 |
| 30 | MP0001851_eye_inflammation | 1.51749049 |
| 31 | MP0005083_abnormal_biliary_tract | 1.43930817 |
| 32 | MP0005595_abnormal_vascular_smooth | 1.40769149 |
| 33 | MP0003828_pulmonary_edema | 1.36381374 |
| 34 | MP0004264_abnormal_extraembryonic_tissu | 1.31058250 |
| 35 | MP0000249_abnormal_blood_vessel | 1.28468045 |
| 36 | MP0000477_abnormal_intestine_morphology | 1.27286916 |
| 37 | MP0001986_abnormal_taste_sensitivity | 1.22095572 |
| 38 | MP0003303_peritoneal_inflammation | 1.19576545 |
| 39 | MP0006054_spinal_hemorrhage | 1.18302999 |
| 40 | MP0003279_aneurysm | 1.13547313 |
| 41 | MP0002405_respiratory_system_inflammati | 1.12758988 |
| 42 | MP0001175_abnormal_lung_morphology | 1.10829786 |
| 43 | MP0003283_abnormal_digestive_organ | 1.10155037 |
| 44 | MP0001440_abnormal_grooming_behavior | 1.09705892 |
| 45 | MP0003186_abnormal_redox_activity | 1.08834638 |
| 46 | MP0002998_abnormal_bone_remodeling | 1.05152672 |
| 47 | MP0005334_abnormal_fat_pad | 1.03005316 |
| 48 | MP0005535_abnormal_body_temperature | 1.02192422 |
| 49 | MP0005647_abnormal_sex_gland | 1.01097932 |
| 50 | MP0003705_abnormal_hypodermis_morpholog | 1.01037750 |
| 51 | MP0005085_abnormal_gallbladder_physiolo | 1.01027044 |
| 52 | MP0003786_premature_aging | 1.00169130 |
| 53 | MP0000462_abnormal_digestive_system | 0.99422520 |
| 54 | MP0001661_extended_life_span | 0.97473009 |
| 55 | MP0009384_cardiac_valve_regurgitation | 0.94559791 |
| 56 | MP0002909_abnormal_adrenal_gland | 0.94296984 |
| 57 | MP0009840_abnormal_foam_cell | 0.93486750 |
| 58 | MP0005503_abnormal_tendon_morphology | 0.90911070 |
| 59 | MP0009115_abnormal_fat_cell | 0.90039175 |
| 60 | MP0000003_abnormal_adipose_tissue | 0.89852645 |
| 61 | MP0005023_abnormal_wound_healing | 0.88838191 |
| 62 | MP0001756_abnormal_urination | 0.86965755 |
| 63 | MP0005448_abnormal_energy_balance | 0.81799009 |
| 64 | MP0005397_hematopoietic_system_phenotyp | 0.78151595 |
| 65 | MP0001545_abnormal_hematopoietic_system | 0.78151595 |
| 66 | MP0000767_abnormal_smooth_muscle | 0.77237474 |
| 67 | MP0005365_abnormal_bile_salt | 0.76717177 |
| 68 | MP0000537_abnormal_urethra_morphology | 0.76274652 |
| 69 | MP0003948_abnormal_gas_homeostasis | 0.75903341 |
| 70 | MP0002136_abnormal_kidney_physiology | 0.75889703 |
| 71 | MP0000490_abnormal_crypts_of | 0.75776653 |
| 72 | MP0001501_abnormal_sleep_pattern | 0.75743387 |
| 73 | MP0003868_abnormal_feces_composition | 0.75311051 |
| 74 | MP0002332_abnormal_exercise_endurance | 0.75218759 |
| 75 | MP0003448_altered_tumor_morphology | 0.74608278 |
| 76 | MP0004858_abnormal_nervous_system | 0.72373722 |
| 77 | MP0005266_abnormal_metabolism | 0.71661289 |
| 78 | MP0008875_abnormal_xenobiotic_pharmacok | 0.71418520 |
| 79 | MP0005387_immune_system_phenotype | 0.71006337 |
| 80 | MP0001790_abnormal_immune_system | 0.71006337 |
| 81 | MP0008775_abnormal_heart_ventricle | 0.68974863 |
| 82 | MP0003115_abnormal_respiratory_system | 0.68812367 |
| 83 | MP0002128_abnormal_blood_circulation | 0.68695878 |
| 84 | MP0003690_abnormal_glial_cell | 0.67699379 |
| 85 | MP0002877_abnormal_melanocyte_morpholog | 0.67344493 |
| 86 | MP0005058_abnormal_lysosome_morphology | 0.66620629 |
| 87 | MP0003959_abnormal_lean_body | 0.65522556 |
| 88 | MP0010329_abnormal_lipoprotein_level | 0.64074997 |
| 89 | MP0002933_joint_inflammation | 0.64045805 |
| 90 | MP0005636_abnormal_mineral_homeostasis | 0.63626564 |
| 91 | MP0001614_abnormal_blood_vessel | 0.62642200 |
| 92 | MP0004185_abnormal_adipocyte_glucose | 0.62222691 |
| 93 | MP0001853_heart_inflammation | 0.62211075 |
| 94 | MP0002234_abnormal_pharynx_morphology | 0.62171559 |
| 95 | MP0002419_abnormal_innate_immunity | 0.62159015 |
| 96 | MP0002138_abnormal_hepatobiliary_system | 0.61498732 |
| 97 | MP0004484_altered_response_of | 0.61015798 |
| 98 | MP0004084_abnormal_cardiac_muscle | 0.60885510 |
| 99 | MP0003329_amyloid_beta_deposits | 0.59815213 |
| 100 | MP0000467_abnormal_esophagus_morphology | 0.57267796 |
| 101 | MP0002796_impaired_skin_barrier | 0.54619300 |
| 102 | MP0003075_altered_response_to | 0.54383351 |
| 103 | MP0010155_abnormal_intestine_physiology | 0.54156823 |
| 104 | MP0003119_abnormal_digestive_system | 0.50315701 |
| 105 | MP0002139_abnormal_hepatobiliary_system | 0.49115727 |
| 106 | MP0003566_abnormal_cell_adhesion | 0.48527222 |
| 107 | MP0004947_skin_inflammation | 0.48361687 |
| 108 | MP0001243_abnormal_dermal_layer | 0.47166201 |
| 109 | MP0001849_ear_inflammation | 0.43795367 |
| 110 | MP0004272_abnormal_basement_membrane | 0.42172633 |
| 111 | MP0002118_abnormal_lipid_homeostasis | 0.39772292 |
| 112 | MP0002019_abnormal_tumor_incidence | 0.37911030 |
| 113 | MP0003866_abnormal_defecation | 0.37903630 |
| 114 | MP0005166_decreased_susceptibility_to | 0.37276282 |
| 115 | MP0002009_preneoplasia | 0.36546821 |
| 116 | MP0003953_abnormal_hormone_level | 0.36277298 |
| 117 | MP0001216_abnormal_epidermal_layer | 0.35996055 |
| 118 | MP0003191_abnormal_cellular_cholesterol | 0.35182485 |
| 119 | MP0002060_abnormal_skin_morphology | 0.34919134 |
| 120 | MP0002078_abnormal_glucose_homeostasis | 0.33957045 |
| 121 | MP0002693_abnormal_pancreas_physiology | 0.33533278 |
| 122 | MP0010678_abnormal_skin_adnexa | 0.33007225 |
| 123 | MP0000604_amyloidosis | 0.32800634 |
| 124 | MP0003453_abnormal_keratinocyte_physiol | 0.32407633 |
| 125 | MP0008873_increased_physiological_sensi | 0.32240684 |
| 126 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.31830403 |
| 127 | MP0005275_abnormal_skin_tensile | 0.31717532 |
| 128 | MP0009780_abnormal_chondrocyte_physiolo | 0.29594993 |
| 129 | MP0010352_gastrointestinal_tract_polyps | 0.28787822 |
| 130 | MP0001845_abnormal_inflammatory_respons | 0.28707709 |
| 131 | MP0000609_abnormal_liver_physiology | 0.28020858 |
| 132 | MP0003638_abnormal_response/metabolism_ | 0.26635992 |
| 133 | MP0000598_abnormal_liver_morphology | 0.26382882 |
| 134 | MP0000367_abnormal_coat/_hair | 0.26042470 |
| 135 | MP0005501_abnormal_skin_physiology | 0.25548090 |
| 136 | MP0008961_abnormal_basal_metabolism | 0.25467532 |
| 137 | MP0005376_homeostasis/metabolism_phenot | 0.24829275 |
| 138 | MP0005319_abnormal_enzyme/_coenzyme | 0.24771830 |
| 139 | MP0002970_abnormal_white_adipose | 0.24478167 |
| 140 | MP0003724_increased_susceptibility_to | 0.24424454 |
| 141 | MP0005408_hypopigmentation | 0.24181147 |
| 142 | MP0003252_abnormal_bile_duct | 0.23957384 |
| 143 | MP0009642_abnormal_blood_homeostasis | 0.23788272 |
| 144 | MP0005310_abnormal_salivary_gland | 0.21601416 |
| 145 | MP0005464_abnormal_platelet_physiology | 0.21070700 |
| 146 | MP0010771_integument_phenotype | 0.20531994 |
| 147 | MP0005332_abnormal_amino_acid | 0.19959369 |
| 148 | MP0009931_abnormal_skin_appearance | 0.19100512 |
| 149 | MP0004130_abnormal_muscle_cell | 0.18715029 |
| 150 | MP0009643_abnormal_urine_homeostasis | 0.18210901 |
| 151 | MP0000013_abnormal_adipose_tissue | 0.17976747 |
| 152 | MP0009053_abnormal_anal_canal | 0.17753346 |
| 153 | MP0001191_abnormal_skin_condition | 0.17507153 |
| 154 | MP0004043_abnormal_pH_regulation | 0.16404642 |
| 155 | MP0005084_abnormal_gallbladder_morpholo | 0.16293692 |
| 156 | MP0000343_altered_response_to | 0.15677902 |
| 157 | MP0005167_abnormal_blood-brain_barrier | 0.15574219 |
| 158 | MP0005360_urolithiasis | 0.15395557 |
| 159 | MP0004019_abnormal_vitamin_homeostasis | 0.15161659 |
| 160 | MP0008438_abnormal_cutaneous_collagen | 0.14749486 |
| 161 | MP0005623_abnormal_meninges_morphology | 0.14442183 |
| 162 | MP0005076_abnormal_cell_differentiation | 0.14413307 |
| 163 | MP0005367_renal/urinary_system_phenotyp | 0.14091144 |
| 164 | MP0000516_abnormal_urinary_system | 0.14091144 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Right ventricular cardiomyopathy (HP:0011663) | 9.41029004 |
| 2 | Abnormality of cells of the erythroid lineage (HP:0012130) | 9.13762777 |
| 3 | Tachypnea (HP:0002789) | 6.67848192 |
| 4 | Systemic lupus erythematosus (HP:0002725) | 5.62187921 |
| 5 | Respiratory distress (HP:0002098) | 5.37943948 |
| 6 | Megaloblastic anemia (HP:0001889) | 4.78979147 |
| 7 | Complement deficiency (HP:0004431) | 4.47371682 |
| 8 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 4.36660339 |
| 9 | Glomerulonephritis (HP:0000099) | 4.30528196 |
| 10 | Abnormality of the fingertips (HP:0001211) | 4.28100873 |
| 11 | Abnormality of complement system (HP:0005339) | 4.16274446 |
| 12 | Palpitations (HP:0001962) | 4.12641880 |
| 13 | Abnormality of vitamin B metabolism (HP:0004340) | 4.11061645 |
| 14 | Acanthosis nigricans (HP:0000956) | 4.03246057 |
| 15 | Woolly hair (HP:0002224) | 3.99183645 |
| 16 | Goiter (HP:0000853) | 3.95280106 |
| 17 | Syncope (HP:0001279) | 3.94427561 |
| 18 | Gout (HP:0001997) | 3.88733546 |
| 19 | Abnormality of vitamin metabolism (HP:0100508) | 3.83953627 |
| 20 | Tubulointerstitial abnormality (HP:0001969) | 3.75431245 |
| 21 | Hyperactive renin-angiotensin system (HP:0000841) | 3.74701210 |
| 22 | Alveolar cell carcinoma (HP:0006519) | 3.61268968 |
| 23 | Intrahepatic cholestasis (HP:0001406) | 3.50919807 |
| 24 | Back pain (HP:0003418) | 3.45973695 |
| 25 | Pulmonary hypertension (HP:0002092) | 3.38021501 |
| 26 | Polycythemia (HP:0001901) | 3.35048141 |
| 27 | Neoplasm of the tracheobronchial system (HP:0100552) | 3.29192512 |
| 28 | Abnormality of purine metabolism (HP:0004352) | 3.19917523 |
| 29 | Nephritis (HP:0000123) | 3.07020566 |
| 30 | Ventricular fibrillation (HP:0001663) | 3.05902387 |
| 31 | Flat acetabular roof (HP:0003180) | 3.05743456 |
| 32 | Hypertriglyceridemia (HP:0002155) | 2.96482224 |
| 33 | Glomerulosclerosis (HP:0000096) | 2.91212941 |
| 34 | Frequent falls (HP:0002359) | 2.84136115 |
| 35 | Hyperkalemia (HP:0002153) | 2.84027449 |
| 36 | Arterial tortuosity (HP:0005116) | 2.78618572 |
| 37 | Hemiplegia (HP:0002301) | 2.77529507 |
| 38 | Vertebral arch anomaly (HP:0008438) | 2.76584200 |
| 39 | Azoospermia (HP:0000027) | 2.70302950 |
| 40 | Bone cyst (HP:0012062) | 2.69698912 |
| 41 | Ventricular arrhythmia (HP:0004308) | 2.69169926 |
| 42 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.68351635 |
| 43 | Eczematoid dermatitis (HP:0000976) | 2.67007220 |
| 44 | Osteolytic defects of the hand bones (HP:0009699) | 2.64156927 |
| 45 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.64156927 |
| 46 | Ventricular tachycardia (HP:0004756) | 2.61280993 |
| 47 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.55322189 |
| 48 | Exertional dyspnea (HP:0002875) | 2.53640961 |
| 49 | Hematochezia (HP:0002573) | 2.52891354 |
| 50 | Micronodular cirrhosis (HP:0001413) | 2.52480426 |
| 51 | Hemorrhage of the eye (HP:0011885) | 2.51111172 |
| 52 | Insulin resistance (HP:0000855) | 2.47299569 |
| 53 | Long toe (HP:0010511) | 2.45632384 |
| 54 | Vascular tortuosity (HP:0004948) | 2.43544825 |
| 55 | Hypergammaglobulinemia (HP:0010702) | 2.42824824 |
| 56 | Increased purine levels (HP:0004368) | 2.41540525 |
| 57 | Hyperuricemia (HP:0002149) | 2.41540525 |
| 58 | Increased IgE level (HP:0003212) | 2.40469707 |
| 59 | Abnormality of the gastric mucosa (HP:0004295) | 2.38176890 |
| 60 | Abnormal cartilage morphology (HP:0002763) | 2.37741673 |
| 61 | Atrophic scars (HP:0001075) | 2.37256291 |
| 62 | Ulnar claw (HP:0001178) | 2.36151147 |
| 63 | Bilateral sensorineural hearing impairment (HP:0008619) | 2.34185370 |
| 64 | Myocardial infarction (HP:0001658) | 2.33677467 |
| 65 | Deep venous thrombosis (HP:0002625) | 2.32783490 |
| 66 | Vascular calcification (HP:0004934) | 2.28980517 |
| 67 | Agitation (HP:0000713) | 2.27192797 |
| 68 | Skin nodule (HP:0200036) | 2.24874977 |
| 69 | Aortic aneurysm (HP:0004942) | 2.24405299 |
| 70 | Decreased circulating renin level (HP:0003351) | 2.23941993 |
| 71 | Focal segmental glomerulosclerosis (HP:0000097) | 2.23385052 |
| 72 | Abdominal distention (HP:0003270) | 2.20236554 |
| 73 | Aortic dissection (HP:0002647) | 2.15850160 |
| 74 | Fragile nails (HP:0001808) | 2.15575250 |
| 75 | Chronic bronchitis (HP:0004469) | 2.15176181 |
| 76 | Epidermoid cyst (HP:0200040) | 2.15033025 |
| 77 | Abnormality of chloride homeostasis (HP:0011422) | 2.14663177 |
| 78 | Macrocytic anemia (HP:0001972) | 2.14353738 |
| 79 | Curly hair (HP:0002212) | 2.13134465 |
| 80 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.12148147 |
| 81 | Abnormality of the periventricular white matter (HP:0002518) | 2.12135451 |
| 82 | Cardiovascular calcification (HP:0011915) | 2.11925010 |
| 83 | Steatorrhea (HP:0002570) | 2.11741252 |
| 84 | Esophageal varix (HP:0002040) | 2.11532522 |
| 85 | Broad metatarsal (HP:0001783) | 2.11483862 |
| 86 | Hyperpituitarism (HP:0010514) | 2.08063638 |
| 87 | Hypoglycemic coma (HP:0001325) | 2.06580972 |
| 88 | Axonal loss (HP:0003447) | 2.05095513 |
| 89 | Sudden cardiac death (HP:0001645) | 2.05022027 |
| 90 | Onycholysis (HP:0001806) | 2.04408586 |
| 91 | Metaphyseal dysplasia (HP:0100255) | 2.04001699 |
| 92 | Spontaneous hematomas (HP:0007420) | 2.03959060 |
| 93 | Glucose intolerance (HP:0000833) | 2.03222127 |
| 94 | Growth hormone excess (HP:0000845) | 2.01050548 |
| 95 | Interstitial pulmonary disease (HP:0006530) | 15.2533998 |
| 96 | Abnormal number of erythroid precursors (HP:0012131) | 10.1661696 |
| 97 | Neoplasm of the lung (HP:0100526) | 1.99674747 |
| 98 | Infantile muscular hypotonia (HP:0008947) | 1.99106071 |
| 99 | Milia (HP:0001056) | 1.98681322 |
| 100 | Malnutrition (HP:0004395) | 1.96632707 |
| 101 | Increased CSF protein (HP:0002922) | 1.95441806 |
| 102 | Short nail (HP:0001799) | 1.94014752 |
| 103 | Hypokalemic alkalosis (HP:0001949) | 1.93739762 |
| 104 | Abnormal hemoglobin (HP:0011902) | 1.92926076 |
| 105 | Abnormal tarsal ossification (HP:0008369) | 1.92261218 |
| 106 | Sensorimotor neuropathy (HP:0007141) | 1.91754783 |
| 107 | Increased variability in muscle fiber diameter (HP:0003557) | 1.91308541 |
| 108 | Seborrheic dermatitis (HP:0001051) | 1.89479607 |
| 109 | Achilles tendon contracture (HP:0001771) | 1.89423459 |
| 110 | Ketoacidosis (HP:0001993) | 1.89094681 |
| 111 | Abnormality of the Achilles tendon (HP:0005109) | 1.88875550 |
| 112 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.88335124 |
| 113 | Cupped ribs (HP:0000887) | 1.88259200 |
| 114 | Progressive sensorineural hearing impairment (HP:0000408) | 1.87939730 |
| 115 | Polygenic inheritance (HP:0010982) | 1.87845380 |
| 116 | Conjugated hyperbilirubinemia (HP:0002908) | 1.85767736 |
| 117 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 1.85604681 |
| 118 | Vertebral hypoplasia (HP:0008417) | 1.85604681 |
| 119 | Pustule (HP:0200039) | 1.83512011 |
| 120 | Lethargy (HP:0001254) | 1.82832358 |
| 121 | Tubulointerstitial nephritis (HP:0001970) | 1.82315810 |
| 122 | Abnormality of nucleobase metabolism (HP:0010932) | 1.79774916 |
| 123 | Testicular neoplasm (HP:0010788) | 1.79271354 |
| 124 | Pulmonary artery stenosis (HP:0004415) | 1.78507325 |
| 125 | Aplasia/Hypoplasia of the abdominal wall musculature (HP:0010318) | 1.77984371 |
| 126 | Spinal cord compression (HP:0002176) | 1.77743805 |
| 127 | Cerebral aneurysm (HP:0004944) | 1.77605911 |
| 128 | Pulmonary fibrosis (HP:0002206) | 1.77308204 |
| 129 | Renal salt wasting (HP:0000127) | 1.77209076 |
| 130 | Recurrent abscess formation (HP:0002722) | 1.75725780 |
| 131 | Ketosis (HP:0001946) | 1.75410512 |
| 132 | Difficulty running (HP:0009046) | 1.74911243 |
| 133 | Large hands (HP:0001176) | 1.74697133 |
| 134 | Visceral angiomatosis (HP:0100761) | 1.74210876 |
| 135 | Tubulointerstitial fibrosis (HP:0005576) | 1.73769268 |
| 136 | Hypotension (HP:0002615) | 1.73727714 |
| 137 | Resting tremor (HP:0002322) | 1.73715353 |
| 138 | Aneurysm (HP:0002617) | 1.73640287 |
| 139 | Xanthomatosis (HP:0000991) | 1.72445326 |
| 140 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.71796196 |
| 141 | Hypoalphalipoproteinemia (HP:0003233) | 1.71609460 |
| 142 | Oligomenorrhea (HP:0000876) | 1.71254554 |
| 143 | Ankyloglossia (HP:0010296) | 1.70850554 |
| 144 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.70192137 |
| 145 | Conjunctival hamartoma (HP:0100780) | 1.70017816 |
| 146 | Hyperaldosteronism (HP:0000859) | 1.69635978 |
| 147 | Microretrognathia (HP:0000308) | 1.69521033 |
| 148 | Protrusio acetabuli (HP:0003179) | 1.69209240 |
| 149 | Difficulty walking (HP:0002355) | 1.68521819 |
| 150 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.68355011 |
| 151 | Mucopolysacchariduria (HP:0008155) | 1.68355011 |
| 152 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.67171955 |
| 153 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.67171955 |
| 154 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.67171955 |
| 155 | Restlessness (HP:0000711) | 1.66704659 |
| 156 | Abnormality of renin-angiotensin system (HP:0000847) | 1.66639774 |
| 157 | Atrioventricular block (HP:0001678) | 1.66274963 |
| 158 | Hyperammonemia (HP:0001987) | 1.66188414 |
| 159 | Neoplasm of the respiratory system (HP:0100606) | 1.65288051 |
| 160 | Abnormal spermatogenesis (HP:0008669) | 1.64837684 |
| 161 | Hyperglycemia (HP:0003074) | 1.64437509 |
| 162 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.64035828 |
| 163 | Wormian bones (HP:0002645) | 1.63909260 |
| 164 | Redundant skin (HP:0001582) | 1.63714790 |
| 165 | Portal hypertension (HP:0001409) | 1.63660409 |
| 166 | Hemangiomatosis (HP:0007461) | 1.63308118 |
| 167 | Abnormality of the intrinsic pathway (HP:0010989) | 1.63023773 |
| 168 | Abnormality of the 1st metacarpal (HP:0010009) | 1.61814141 |
| 169 | Abnormal pancreas size (HP:0012094) | 1.60789972 |
| 170 | Paresthesia (HP:0003401) | 1.60771073 |
| 171 | Striae distensae (HP:0001065) | 1.60724573 |
| 172 | Camptodactyly of toe (HP:0001836) | 1.60646394 |
| 173 | Plantar hyperkeratosis (HP:0007556) | 1.58737232 |
| 174 | Sudden death (HP:0001699) | 1.58274692 |
| 175 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.57662316 |
| 176 | Fat malabsorption (HP:0002630) | 1.56235036 |
| 177 | Accelerated skeletal maturation (HP:0005616) | 1.55858328 |
| 178 | Hypoplastic left heart (HP:0004383) | 1.54909981 |
| 179 | Stridor (HP:0010307) | 1.54573527 |
| 180 | Turricephaly (HP:0000262) | 1.54513139 |
| 181 | Hydroureter (HP:0000072) | 1.52956394 |
| 182 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.51182344 |
| 183 | Rapidly progressive (HP:0003678) | 1.50880001 |
| 184 | Congenital, generalized hypertrichosis (HP:0004540) | 1.50477340 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MST4 | 4.62943673 |
| 2 | MST1R | 4.27847844 |
| 3 | TGFBR2 | 3.03210572 |
| 4 | EPHA3 | 2.69932379 |
| 5 | TRIB3 | 2.35346159 |
| 6 | PKN2 | 2.05537876 |
| 7 | ERBB4 | 12.8112933 |
| 8 | LRRK2 | 1.94730082 |
| 9 | MET | 1.73784735 |
| 10 | LATS2 | 1.69441387 |
| 11 | FGFR4 | 1.69317563 |
| 12 | KSR2 | 1.68837841 |
| 13 | MAP3K6 | 1.62728290 |
| 14 | STK38L | 1.61210902 |
| 15 | MAP3K2 | 1.56321424 |
| 16 | NLK | 1.54222636 |
| 17 | MAPK15 | 1.52941554 |
| 18 | NEK6 | 1.47229902 |
| 19 | MAP3K9 | 1.47048125 |
| 20 | PRKAA2 | 1.44483396 |
| 21 | NME2 | 1.39049596 |
| 22 | RIPK4 | 1.37924037 |
| 23 | MAP2K2 | 1.36106503 |
| 24 | MAPK7 | 1.33411532 |
| 25 | MAPK12 | 1.31128585 |
| 26 | LATS1 | 1.30807333 |
| 27 | PIK3CG | 1.30067101 |
| 28 | AKT3 | 1.28604622 |
| 29 | MAP2K1 | 1.27152807 |
| 30 | FER | 1.22404148 |
| 31 | STK10 | 1.21488556 |
| 32 | BRD4 | 1.15851286 |
| 33 | STK38 | 1.15274877 |
| 34 | PRPF4B | 1.15096622 |
| 35 | PTK6 | 1.11298570 |
| 36 | IRAK1 | 1.08111587 |
| 37 | ERN1 | 1.04141580 |
| 38 | LMTK2 | 1.03113255 |
| 39 | PRKG2 | 0.99441572 |
| 40 | MAPK4 | 0.98514121 |
| 41 | BCKDK | 0.96267936 |
| 42 | RIPK1 | 0.93162478 |
| 43 | PRKCI | 0.92720021 |
| 44 | FGFR3 | 0.91823583 |
| 45 | GSK3A | 0.89597583 |
| 46 | NME1 | 0.89587950 |
| 47 | PAK3 | 0.87353937 |
| 48 | JAK1 | 0.86534974 |
| 49 | MAP3K14 | 0.86351852 |
| 50 | TYK2 | 0.82003231 |
| 51 | NEK1 | 0.81578004 |
| 52 | TESK1 | 0.80593503 |
| 53 | STK39 | 0.79598512 |
| 54 | NEK9 | 0.79428662 |
| 55 | MYLK | 0.78408038 |
| 56 | FYN | 0.77665848 |
| 57 | MAP3K13 | 0.77582351 |
| 58 | NUAK1 | 0.76371992 |
| 59 | PAK4 | 0.75624054 |
| 60 | TAOK1 | 0.74155427 |
| 61 | WNK4 | 0.73974592 |
| 62 | FRK | 0.73055955 |
| 63 | DDR2 | 0.72084737 |
| 64 | JAK2 | 0.72007040 |
| 65 | PDGFRB | 0.69909770 |
| 66 | RPS6KB2 | 0.68066858 |
| 67 | PBK | 0.67724599 |
| 68 | GRK5 | 0.67545132 |
| 69 | YES1 | 0.67427925 |
| 70 | ROCK2 | 0.66057930 |
| 71 | ICK | 0.63830662 |
| 72 | CDC42BPA | 0.62402849 |
| 73 | MAP3K8 | 0.60286320 |
| 74 | DAPK2 | 0.60283011 |
| 75 | MAPK3 | 0.57915362 |
| 76 | ABL2 | 0.57665700 |
| 77 | BMX | 0.57177996 |
| 78 | KIT | 0.57010443 |
| 79 | TRPM7 | 0.54320363 |
| 80 | MARK2 | 0.53751393 |
| 81 | PTK2 | 0.53552613 |
| 82 | MAP3K3 | 0.53285187 |
| 83 | SGK3 | 0.52400015 |
| 84 | HIPK2 | 0.52316163 |
| 85 | ZAP70 | 0.52136741 |
| 86 | PDK4 | 0.51651902 |
| 87 | PDK3 | 0.51651902 |
| 88 | EPHB1 | 0.51100025 |
| 89 | CAMK1D | 0.49902248 |
| 90 | JAK3 | 0.49533011 |
| 91 | SRC | 0.49394308 |
| 92 | KDR | 0.46912528 |
| 93 | ARAF | 0.46608634 |
| 94 | MOS | 0.46459058 |
| 95 | RET | 0.45881587 |
| 96 | TYRO3 | 0.44708990 |
| 97 | CDK6 | 0.44549062 |
| 98 | SGK2 | 0.44339966 |
| 99 | MTOR | 0.43901485 |
| 100 | PDPK1 | 0.43231321 |
| 101 | ERBB2 | 0.43073143 |
| 102 | RPS6KA2 | 0.42600263 |
| 103 | INSR | 0.42256581 |
| 104 | STK24 | 0.42111752 |
| 105 | EEF2K | 0.42083126 |
| 106 | MAPKAPK3 | 0.41664801 |
| 107 | FES | 0.40798926 |
| 108 | SIK1 | 0.40654830 |
| 109 | MAP3K7 | 0.39900265 |
| 110 | GRK1 | 0.39836725 |
| 111 | MATK | 0.39786388 |
| 112 | CDK19 | 0.39645734 |
| 113 | IGF1R | 0.38882420 |
| 114 | BLK | 0.38760990 |
| 115 | ROCK1 | 0.38627876 |
| 116 | LIMK1 | 0.36922043 |
| 117 | MAPK1 | 0.36843149 |
| 118 | WNK1 | 0.36420794 |
| 119 | MAP3K1 | 0.36388585 |
| 120 | CAMKK2 | 0.34868607 |
| 121 | MAP3K11 | 0.31488294 |
| 122 | TTN | 0.31197904 |
| 123 | CAMKK1 | 0.30758985 |
| 124 | ILK | 0.30599768 |
| 125 | GRK6 | 0.30402781 |
| 126 | CAMK2B | 0.30224111 |
| 127 | PDK2 | 0.30154813 |
| 128 | MAP3K10 | 0.30044657 |
| 129 | SCYL2 | 0.28763161 |
| 130 | TIE1 | 0.28747005 |
| 131 | DMPK | 0.28242509 |
| 132 | PDK1 | 0.28204470 |
| 133 | DAPK3 | 0.28068298 |
| 134 | CSK | 0.27264065 |
| 135 | CAMK2G | 0.25011800 |
| 136 | EGFR | 0.24991775 |
| 137 | PDGFRA | 0.23975270 |
| 138 | CAMK2D | 0.23466678 |
| 139 | ALK | 0.23018819 |
| 140 | PRKD1 | 0.23005292 |
| 141 | FGR | 0.22406778 |
| 142 | NTRK1 | 0.21859806 |
| 143 | PIM2 | 0.21245241 |
| 144 | MINK1 | 0.19966921 |
| 145 | EPHB2 | 0.18781273 |
| 146 | PAK1 | 0.18126779 |
| 147 | PRKCQ | 0.15975278 |
| 148 | TBK1 | 0.15163436 |
| 149 | KSR1 | 0.14914871 |
| 150 | RAF1 | 0.13867972 |
| 151 | ADRBK1 | 0.13421524 |
| 152 | RPS6KA1 | 0.11662039 |
| 153 | PHKG1 | 0.11407680 |
| 154 | PHKG2 | 0.11407680 |
| 155 | PAK6 | 0.11387499 |
| 156 | PAK2 | 0.10954048 |
| 157 | EPHA2 | 0.10222646 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 5.41097243 |
| 2 | Gastric acid secretion_Homo sapiens_hsa04971 | 4.66913387 |
| 3 | Sulfur metabolism_Homo sapiens_hsa00920 | 4.66635169 |
| 4 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 4.33563121 |
| 5 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 4.33244867 |
| 6 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 3.98356820 |
| 7 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 3.81308159 |
| 8 | Glutathione metabolism_Homo sapiens_hsa00480 | 3.53879266 |
| 9 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.96980566 |
| 10 | Pertussis_Homo sapiens_hsa05133 | 2.81523166 |
| 11 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.63331656 |
| 12 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.56085723 |
| 13 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 2.41786649 |
| 14 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.37082863 |
| 15 | Protein digestion and absorption_Homo sapiens_hsa04974 | 2.29628416 |
| 16 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.23861432 |
| 17 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.97381750 |
| 18 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.85365413 |
| 19 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.82500441 |
| 20 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.78989427 |
| 21 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.72924061 |
| 22 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.60594051 |
| 23 | Phagosome_Homo sapiens_hsa04145 | 1.54550005 |
| 24 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.43865359 |
| 25 | Mineral absorption_Homo sapiens_hsa04978 | 1.34488800 |
| 26 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.32900745 |
| 27 | Malaria_Homo sapiens_hsa05144 | 1.27244533 |
| 28 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.25939165 |
| 29 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.25551606 |
| 30 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.25334186 |
| 31 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.24588142 |
| 32 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.23484208 |
| 33 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.19772556 |
| 34 | Retinol metabolism_Homo sapiens_hsa00830 | 1.14391196 |
| 35 | Asthma_Homo sapiens_hsa05310 | 1.12945944 |
| 36 | Other glycan degradation_Homo sapiens_hsa00511 | 1.12237882 |
| 37 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.11360550 |
| 38 | Circadian rhythm_Homo sapiens_hsa04710 | 1.09798469 |
| 39 | Viral myocarditis_Homo sapiens_hsa05416 | 1.05268576 |
| 40 | Sulfur relay system_Homo sapiens_hsa04122 | 1.03679288 |
| 41 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.00844172 |
| 42 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.97982070 |
| 43 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.92982700 |
| 44 | Hepatitis C_Homo sapiens_hsa05160 | 0.92777278 |
| 45 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.91892635 |
| 46 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.91337446 |
| 47 | Insulin resistance_Homo sapiens_hsa04931 | 0.90845658 |
| 48 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.89025448 |
| 49 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.87767765 |
| 50 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.87422727 |
| 51 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.85176999 |
| 52 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.84748121 |
| 53 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.84413007 |
| 54 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.84400657 |
| 55 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.81102426 |
| 56 | Bile secretion_Homo sapiens_hsa04976 | 0.79955586 |
| 57 | Leishmaniasis_Homo sapiens_hsa05140 | 0.79925200 |
| 58 | Allograft rejection_Homo sapiens_hsa05330 | 0.77472786 |
| 59 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.76554247 |
| 60 | Prion diseases_Homo sapiens_hsa05020 | 0.74418495 |
| 61 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.74030565 |
| 62 | Histidine metabolism_Homo sapiens_hsa00340 | 0.74015726 |
| 63 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.71477207 |
| 64 | Carbon metabolism_Homo sapiens_hsa01200 | 0.71420548 |
| 65 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.71338199 |
| 66 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.70849600 |
| 67 | Renin secretion_Homo sapiens_hsa04924 | 0.70170572 |
| 68 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.68531512 |
| 69 | Tight junction_Homo sapiens_hsa04530 | 0.68075571 |
| 70 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.67689060 |
| 71 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.65068178 |
| 72 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.64705549 |
| 73 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.63587650 |
| 74 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.63098445 |
| 75 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.62661848 |
| 76 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.62069509 |
| 77 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.61783539 |
| 78 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.60444963 |
| 79 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.58680818 |
| 80 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.57507161 |
| 81 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.57266174 |
| 82 | Amoebiasis_Homo sapiens_hsa05146 | 0.56690278 |
| 83 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.56616723 |
| 84 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.56287653 |
| 85 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.56093415 |
| 86 | Influenza A_Homo sapiens_hsa05164 | 0.55820482 |
| 87 | Thyroid cancer_Homo sapiens_hsa05216 | 0.52923434 |
| 88 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.52400353 |
| 89 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.52225210 |
| 90 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.51947054 |
| 91 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.51846094 |
| 92 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.49160905 |
| 93 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.48707368 |
| 94 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.48308059 |
| 95 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.47358856 |
| 96 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.47236484 |
| 97 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.46171881 |
| 98 | Lysosome_Homo sapiens_hsa04142 | 0.45752021 |
| 99 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.45432217 |
| 100 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.45348070 |
| 101 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.45296877 |
| 102 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.45199382 |
| 103 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.44097686 |
| 104 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.43554121 |
| 105 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.42523352 |
| 106 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.41174656 |
| 107 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.39213591 |
| 108 | Tuberculosis_Homo sapiens_hsa05152 | 0.37843054 |
| 109 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.37694968 |
| 110 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.37349161 |
| 111 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.36975664 |
| 112 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.36194619 |
| 113 | Bladder cancer_Homo sapiens_hsa05219 | 0.34328415 |
| 114 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.33019789 |
| 115 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.32541931 |
| 116 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.32386575 |
| 117 | Adherens junction_Homo sapiens_hsa04520 | 0.32376044 |
| 118 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.32278242 |
| 119 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.31926068 |
| 120 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.31805511 |
| 121 | Shigellosis_Homo sapiens_hsa05131 | 0.30795133 |
| 122 | Salmonella infection_Homo sapiens_hsa05132 | 0.29507772 |
| 123 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.29097326 |
| 124 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.26848142 |
| 125 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.25990070 |
| 126 | Galactose metabolism_Homo sapiens_hsa00052 | 0.24882196 |
| 127 | Alzheimers disease_Homo sapiens_hsa05010 | 0.24298933 |
| 128 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.23922213 |
| 129 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.23448638 |
| 130 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.23326422 |
| 131 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.23313088 |
| 132 | Salivary secretion_Homo sapiens_hsa04970 | 0.21264686 |
| 133 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.20629521 |
| 134 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.17731066 |
| 135 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.17495890 |
| 136 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.15688778 |
| 137 | Focal adhesion_Homo sapiens_hsa04510 | 0.15503965 |
| 138 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.14832915 |
| 139 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.12893362 |
| 140 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.12016175 |
| 141 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.11528459 |
| 142 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.11296841 |
| 143 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.10811824 |
| 144 | Peroxisome_Homo sapiens_hsa04146 | 0.09927881 |
| 145 | Metabolic pathways_Homo sapiens_hsa01100 | 0.09917403 |
| 146 | ABC transporters_Homo sapiens_hsa02010 | 0.08399453 |
| 147 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.07842894 |
| 148 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.07225678 |
| 149 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.06647382 |
| 150 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.06462585 |
| 151 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.06209820 |
| 152 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.05954890 |
| 153 | Platelet activation_Homo sapiens_hsa04611 | 0.05574387 |

